2022 Critical Care Pharmacy Preparatory Review and Recertification Course -- Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development, Supportive and Preventive Medicine, and Neurocritical Care

Saturday, April 23, 2022 from 8:00 AM to 11:30 AM CDT
at Academic and Research Building: Second Floor, Room 223
Available for 3.50 hours of CPE credit
Activity Number: 0217-0000-22-089-L04-P

The Critical Care Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Board of Pharmacy Specialties (BPS) Critical Care Pharmacy Specialty Certification Examination, for Board Certified Critical Care Pharmacists (BCCCPs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of critical care pharmacy topics.

Developed and presented by nationally recognized pharmacy faculty, the course content provides a comprehensive review of the knowledge domains covered in the critical care pharmacy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Describe landmark events in the evolution of critical care pharmacy as a specialty, including summarizing key published documents and evidence validating critical care pharmacy as a specialty.
2. Identify the core knowledge area for pharmacists caring for critically ill patients.
3. Summarize the findings from key studies documenting the association of critical care pharmacy services with favorable health care outcomes.
4. List the criteria for credentialing and training pharmacists who provide critical care services at the desired and optimal levels as outlined in the 2011 American College of Clinical Pharmacy (ACCP) critical care "PRN Opinion Paper," in addition to critical care training opportunities and growth.
5. Outline the standards of practice for clinical pharmacy in the critical care practice environment including using a standard process of care.
6. Develop an approach to conducting a gap analysis relative to the principles and values of team-based care in a local critical care practice environment.
7. Differentiate between the conventional and nontraditional pathways of training to obtain knowledge, skills, and attitudes for critical care pharmacy practice, including the key features of a mentor-mentee (protege) relationship in the training of critical care pharmacists.
8. Develop an approach to lifelong professional learning to maintain competency in critical care pharmacy practice using the principles of continuing professional development, including the many educational components or techniques that can be incorporated into a personal development plan.
9. Identify the avenues and processes for contributing to the critical care body of knowledge as a presenter, author, or peer reviewer.
10. Identify the key components of intensive care medicine that can be applied to all critically ill patients.
11. Recommend therapeutic options to prevent stress-related mucosal disease.
12. Recommend therapeutic options to prevent venous thromboembolism in a critically ill patient.
13. Compare therapeutic options for patients with heparin- induced thrombocytopenia.
14. Discuss medications that can be used to comfort a critically ill patient at the end of life.
15. Identify pertinent pathophysiologic and laboratory changes that acutely occur after neurologic injuries and require therapeutic intervention.
16. Describe monitoring devices commonly used in neurocritical care patients that help develop and optimize treatment strategies.
17. Develop an evidence-based treatment strategy for neurocritical care patients that optimizes patient outcomes and reduces the risk of adverse drug effects and drug interactions.
18. Recommend a monitoring plan to assess response to therapeutic regimens and specific therapeutic goals for neurocritical care patients.
19. Reassess and develop new plans of care for neurocritical care patients according to therapeutic and adverse outcomes and progress toward therapeutic goals.

Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development 8:00 AM to 9:15 AM Speakers Speaker: Curtis E. Haas, Pharm.D., FCCP Chief Pharmacy Officer University of Rochester Medical Center Rochester, New York View Biography Haas Speaker: Bradley A. Boucher, Pharm.D., FCCP, FNAP, MCCM View Biography Boucher

Supportive and Preventive Medicine 9:15 AM to 9:55 AM Speakers Speaker: Sara Radparvar, Pharm.D., BCCCP Critical Care Pharmacist Specialist The Mount Sinai Hospital New York, New York View Biography Radparvar

Neurocritical Care 10:05 AM to 11:30 AM Speakers Speaker: Eljim P. Tesoro, Pharm.D., BCCCP Clinical Associate Professor, University of Illinois at Chicago College of Pharmacy Clinical Pharmacist, Neurocritical Care, University of Illinois Health Chicago, Illinois View Biography Tesoro